New directions in the genetic mechanisms underlying nicotine addiction

Addiction Biology

Volumn 6, Issue 2, 2001, Pages 109-117

  Munafò, Marcus ^a   Johnstone, Elaine ^a   Murphy, Michael ^a   Walton, Robert ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; CLONIDINE; DOPAMINE; MECAMYLAMINE; NICOTINE;

ADAPTATION; BEHAVIOR; DOPAMINERGIC SYSTEM; ENVIRONMENTAL FACTOR; FACILITATION; GENETIC ANALYSIS; HEREDITY; PERSONALITY; PRIORITY JOURNAL; REVIEW; SMOKING; SMOKING CESSATION; TOBACCO DEPENDENCE; WITHDRAWAL SYNDROME;

EID: 0035015134     PISSN: 13556215     EISSN: None     Source Type: Journal    
DOI: 10.1080/13556210020040181     Document Type: Review

References (50)

1. 1. Stitzel JA, Robinson SF, Marks MJ, Collins AC. Differences in response to nicotine are determined by genetic factors. In: Clarke PBS, Quik M, Adikofer F, Thurau K, editors. The effects of nicotine on biological systems. Basel: Bikhauser Verlag; 1995, pp. 279-286.
2. 2. Gilbert DG, Gilbert BO. Personality, psychopathology, and nicotine response as mediators of the genetics of smoking. Behav Genet 1995;25: 133-47.
3. 3. Heath AC, Madden PAF. Genetic influences on smoking behavior. In: Turner JR, Cardon LR, Hewitt JK, editors. Behavior genetic approaches in behavioral medicine. New York: Plenum Press; 1995, pp. 45-66.
4. 4. Kendler KS, Neale MC, Sullivan P, Corey LA, Gardner CO, Prescott CA. A population-based twin study in women of smoking initiation and nicotine dependence. Psychol Med 1999;29: 299-308.
5. 5. True WR, Xian H, Scherrer JF, et al. Common genetic vulnerability for nicotine and alcohol dependence in men. Arch Gen Psychiatry 1999;56:655-61.
6. 6. True WR, Heath AC, Scherrer JF, et al. Genetic and environmental contributions to smoking. Addiction 1997;92:1277-87.
7. 7. Heath AC, Cates RC, Martin NG, et al. Genetic contribution to risk of smoking initiation: comparison across birth cohorts and across cultures. J Subst Abuse 1993;5:221-46.
8. 8. Niu T, Chen C, Ni J, et al. Nicotine dependence and its familial aggregation in Chinese. Int J Epidemiol 2000;29:248-52.
9. 9. Heath AC, Martin NG. Genetic models for the natural history of smoking: evidence for a genetic influence on smoking persistence. Addict Behav 1993;18;19-34.
10. 10. Ishikawa H, Ohtsuki T, Ishiguro H, et al. Association between serotonin transporter gene polymorhism and smoking among Japanese males. Cancer Epidemiol Biomarkers Prev 1999;8:831-3.
11. 11. Sabol SZ, Nelson ML, Fisher C, et al. A genetic association for cigarette smoking behavior. Health Psychol 1999;18:7-13.
12. 12. London SJ, Idle JR, Daly AK, Coetzee GA. Genetic variation of CYP2A6, smoking and risk of cancer [letter]. Lancet 1999;353:898-9.
13. 13. Spitz MR, Shi H, Yang F, et al. Case-control study of the D2 dopamine receptor gene and smoking status in lung cancer patients. J Natl Cancer Inst 1998;90:358-63.
14. 14. Comings DE, Ferry L, Bradshaw-Robinson S, Burchette R, Chiu C, Muhleman D. The dopamine D2 receptor (DRD2) gene: a genetic risk factor in smoking. Pharmacogenetics 1997;6:73-9.
15. 15. Noble EP, St Jeor ST, Ritchie T, et al. D2 dopamine receptor gene and cigarette smoking: a reward gene? Med Hypotheses 1994;42:257-60.
16. 16. Shields PG, Lerman C, Audrain J, et al. Dopamine D4 receptors and the risk of cigarette smoking in African-Americans and Caucasians. Cancer Epidemiol Biomarkers Prev 1998;7:453-8.
17. 17. Lerman C, Caporaso NE, Audrain J, et al. Evidence suggesting the role of specific genetic factors in cigarette smoking. Health Psychol 1999;18: 14-20.
18. 18. Caporaso N, Lerman C, Main D, et al. The genetic of smoking: the dopamine receptor (DRD2) and transporter polymorphisms in a smoking cessation study. Proc Am Assoc Cancer Res 1997;38:168.
19. 19. Cholerton S, Boustead C, Taber H, Arpanahi A, Idle JR. CYP2D6 genotypes in cigarette smokers and non-tobacco users. Pharmacogenetics 1996;6:261-3.
20. 20. Lerman C, Shields PG, Audrain J, et al. The role of the serotonin transporter gene in cigarette smoking. Cancer Epidemiol Biomarkers Prev 1998;7:253-5.
21. 21. Turgeon J, Labbe L, Lefez C, Lebel M. Debrisoquine metabolic ratio (DMR) distribution differs among smokers and non-smokers. Am Soc Clin Pharmacol Ther 1995;P161:150.
22. 22. Garcia-Closas M, Caporaso N, Kelsey K, Christiani D. Association between CYP1A1 polymorphism and smoking in a control population: implications for the study of genetic factors on cancer risk. Proc Am Assoc Cancer Res 1997;38:211.
23. 23. Boustead C, Taber H, Idle JR, Cholerton S. CYP2D6 genotype and smoking behaviour in cigarette smokers. Pharmacogenetics 1997;7: 411-14.
24. 24. Lerman C, Shields PG, Main D, et al. Lack of association of tyrosine hydroxylase genetic polymorphism with cigarette smoking. Pharmacogenetics 1997;7:521-4.
25. 25. McKinney E, Walton RT, Yudkin P, et al. Association between polymorphisms in dopamine metabolic enzymes and tobacco consumption in smokers. Pharmacogenetics 2000;10:483-91.
26. 26. Pianezza ML, Sellers EM, Tyndale RF. Nicotine metabolism defect reduces smoking. Nature 1998;393:750.
27. 27. Oscarson M, McLellan RA, Gullsten H, et al. Identification and characterisation of novel polymorphisms in the CYP2A locus: implications for nicotine metabolism. FEBS Lett 1999;460: 321-7.
28. 28. Singleton AB, Thomson JH, Morris CM, Court JA, Lloyd S, Cholerton S. Lack of association between the dopamine D2 receptor gene allele DRD2*A1 and cigarette smoking in a United Kingdom population. Pharmacogenetics 1998;8: 125-8.
29. 29. Bierut LJ, Rice JP, Edenberg HJ, Family-based study of the association of the dopamine D2 receptor gene (DRD2) with habitual smoking. Am J Med Genet 2000;90:299-302.
30. 30. Patton D, Barnes GE, Murray RP. A personality typology of smokers. Addict Behav 1997;22: 269-73.
31. 31. White V, Hill D, Hopper J. The outgoing, the rebellious and the anxious: are adolescent personality dimensions related to the uptake of smoking? Psychol Health 1996;12:73-85.
32. 32. Papakyriazi E, Joseph S. Individual differences in personality among smokers and their association with smoking motivation, social skills deficit, and self-efficacy to quit. Pers Individ Diff 1998;25: 621-6.
33. 33. Gray JA. A critique of Eysenck's theory of personality. In: Eysenck HJ, editor. A model for personality. New York: Springer; 1981.
34. 34. Swan GE, Carmelli D, Rosenman RH. Psychological characteristics in twins discordant for smoking behavior: a matched-twin-pair analysis. Addict Behav 1988;13:51-60.
35. 35. Netter P, Hennig J, Roed IS. Serotonin and dopamine as mediators of sensation seeking. Neuropsychobiology 1996;34:155-65.
36. 36. Carton S, Jouvent R, Widlocher D. Sensation seeking, nicotine dependence, and smoking motivation in female and male smokers. Addict Behav 1994;19:219-27.
37. 37. Canals J, Blade J, Domenech E. Smoking and personality predictors in Spanish people. Pers Individ Diff 1997;23:905-8.
38. 38. Benowitz NL. Nicotine addiction. Primary Care 1999;26:611-31.
39. 39. Delfs JM, Zhu Y, Druhan JP, Aston-Jones G. Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion. Nature 2000;403:430-4.
40. 40. Ise Y, Narita M, Nagase H, Suzuki T. Modulation of opioidergic system on mecamylamine-precipitated nicotine-withdrawal aversion in rats. Psychopharmacology 2000;151:49-54.
41. 41. Robinson TE, Berridge KC. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Rev 1993;18:247-91.
42. 42. Schulteis G, Ahmed SH, Morse AC, Koob GF, Everitt BJ. Conditioning and opiate withdrawal. Nature 2000;405;1013-14.
43. 43. Balfour DJK. Neural mechanisms underlying nicotine addiction. Addiction 1994;89:1419-23.
44. 44. Mansvelder HD, McGehee DS. Long-term potentiation of excitatory inputs to brain reward areas by nicotine. Neuron 2000;27:349-57.
45. 45. Waters AJ, Feyerabend C. Determinants and effects of attentional bias in smokers. Psychol Addict Behav 2000;14:111-20.
46. 46. Koob GF, Le Moal M. Drug abuse: hedonic homeostatic dysregulation. Science 1997;278: 52-7.
47. 47. Solomon RL. Opponent process theory. In: Maser JD, Seligman MEP, editors. Psychopathology: experimental models. San Francisco: Freeman; 1977.
48. 48. Royal College of Physicians. Nicotine addiction in Britain. London: Royal College of Physicians; 2000.
49. 49. American Medical Association. A clinical practice guideline for treating tobacco use and dependence. J Am Med Assoc 2000;283:3244-54.
50. 50. Hughes JR, Stead LF, Lancaster T. Antidepressants for smoking cessation. In: Cochrane Library, Issue 4. Oxford: Update Software; 2000.